Atlas Drug-Eluting Coronary Stents Inhibit Neointimal Hyperplasia in Sheep Modeling.

The results in this study showed a significant reduction in neointimal hyperplasia after experimental implantation of Atlas Drug-eluting Coronary Stents coated with PLGA polymer. Pharmacokinetic studies also showed that the stent did not release a significant amount of sirolimus after 28 days.

Authors

Raşit Dinç (ORCID: https://orcid.org/0000-0003-1382-0262)
Halit Yerebakan

Institutions

Yeditepe University (TR)

Publication Details

Journal: PubMed
Published: 2024-09-01
DOI: https://doi.org/10.6515/acs.202409_40(5).20240618a
Citations: 4
Primary Topic: Coronary Interventions and Diagnostics
Type: article
Field-Weighted Citation Impact: 1.72

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Atlas Drug-Eluting Coronary Stents Inhibit Neointimal Hyperplasia in Sheep Modeling.

Raşit Dinç, Halit Yerebakan

Sep 1, 2024

4 citations

PubMed

Coronary Interventions and Diagnostics

1.72

article

Atlas Drug-Eluting Coronary Stents Inhibit Neointimal Hyperplasia in Sheep Modeling.

Raşit Dinç, Halit Yerebakan

September 1, 2024article en

4 citations

Abstract

PubMedVol. 40(5)

Yeditepe University (TR)

Openalex Percentile: Top 15%

Coronary Interventions and Diagnostics

1.72

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Atlas Drug-Eluting Coronary Stents Inhibit Neointimal Hyperplasia in Sheep Modeling. — Raşit Dinç, Halit Yerebakan · PubMed (2024) | TGRS Research Map | TGRS